Physician profile
James G Ames
NPI 1811998933
$1,133.25
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $164 · 2021: $261 · 2022: $232 · 2023: $53.73 · 2024: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $163.24 | 2019-2021 | |
| Abbott Laboratories | $150.21 | 2021-2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $99.07 | 2019-2021 | |
| Novo Nordisk INC | $88.28 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $75.91 | 2019-2023 | Breztri |
| Merck Sharp & Dohme LLC | $71.59 | 2019-2021 | |
| Pfizer INC. | $69.71 | 2019-2024 | |
| Glaxosmithkline, LLC. | $63.75 | 2020-2021 | |
| Abbvie INC. | $46.30 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.99 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $40.69 | 2021-2022 | |
| Sanofi Pasteur INC. | $36.20 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.69 | 2021 | |
| Exact Sciences Corporation | $20.89 | 2023 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $18.80 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17.20 | 2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $16.76 | 2022 | |
| Csl Behring | $16.29 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.71 | 2022 | |
| Esperion Therapeutics, INC. | $14.82 | 2020 | |
| Xeris Pharmaceuticals, INC. | $13.35 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.13 | 2022 | |
| Amarin Pharma, INC. | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.